Soligenix (SNGX) EBT Margin (QoQ) (2010 - 2024)
Soligenix (SNGX) EBT Margin (QoQ) (2010 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Soligenix | 6.45 Mn | 6.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -6.86 Mn |
| Mar 31, 2024 | -64,546.00 |
| Dec 31, 2023 | 28,352.00 |
| Sep 30, 2023 | -49,566.00 |
| Jun 30, 2023 | 7,926.00 |
| Mar 31, 2023 | 16,709.00 |
| Dec 31, 2022 | 96,632.00 |
| Sep 30, 2022 | -44,267.00 |
| Jun 30, 2022 | 76,351.00 |
| Mar 31, 2022 | -60,609.00 |
| Dec 31, 2021 | 22,029.00 |
| Sep 30, 2021 | -64,112.00 |
| Jun 30, 2021 | 31,506.00 |
| Mar 31, 2021 | -82,541.00 |
| Dec 31, 2020 | -48,122.00 |
| Sep 30, 2020 | 25,550.00 |
| Jun 30, 2020 | 36,098.00 |
| Mar 31, 2020 | -76,567.00 |
| Dec 31, 2019 | 14,246.00 |
| Sep 30, 2019 | -8,714.00 |